Skip to Content

LEO Pharma

Articles

Beskyttet: Norwegian dermatologists’ experience in treating moderate-to-severe plaque psoriasis with brodalumab in relation to clinical trials

  • / LEO Pharma / Tore Morken / Evelina Buinauskaite / Ernst Veer / Thrasyvoulos Tzellos
Back to top